卵巢上皮癌的细胞减灭术是一公认的重要治疗措施,许多作者提出在首次手术后,残存灶极小的病人改善了生存率。作者报道1977年1月1日～1984年12月31日在 Anderson 肿瘤中心的115例患者进行第二次细胞减灭术。所有患者于第一次减灭术后均接受了化疗。其中33例在完成预定化疗前,因临床发现疾病稳定(2例)和疾病进展(31例)而进行第二次细胞减灭术。33例诊断时平均年龄54岁。按 FIGO 标准:Ⅰ+Ⅱ期18％,Ⅲ期67％,Ⅳ期9％,未分期6％。病理分级:Ⅰ级6％,Ⅱ级24％,Ⅲ级58％,未分级12％。组织学类型:浆液性42％,未分化癌12％,糖液性9％,内膜样癌9％,透明细胞癌9％,棍合性癌18％。手术力求彻底,主要范围是:切除肿瘤而不包 Cytoreductive surgery for ovarian epithelial cancer is a well-recognized and important treatment and many authors propose that patients with minimal residual disease improve survival after first surgery. The authors reported that a second cytoreductive surgery was performed in 115 patients at the Anderson Cancer Center from January 1, 1977 to December 31, All patients received chemotherapy after the first abatement. Of the 33 cases, the second cytoreductive surgery was performed before the scheduled chemotherapy was completed due to the clinical finding of stable disease (2 cases) and disease progression (31 cases). 33 cases were diagnosed with an average age of 54 years. According to FIGO standard: Ⅰ + Ⅱ 18%, Ⅲ 67%, Ⅳ 9%, not 6%. Pathological grade: Ⅰ grade 6%, Ⅱ grade 24%, Ⅲ grade 58%, not graded 12%. Histological types: serous 42%, undifferentiated carcinoma 12%, 9% sugar liquid, endometrioid carcinoma 9%, 9% of clear cell carcinoma, sticky cancer 18%. Surgery to complete, the main scope is: removal of the tumor without package